Technical Analysis for BAX - Baxter International Inc.

Grade Last Price % Change Price Change
grade D 82.25 0.30% 0.25
BAX closed up 0.3 percent on Thursday, November 21, 2019, on 74 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical BAX trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Cup with Handle Other 0.00%
Outside Day Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.30%
Cup with Handle Other 0.30%
Overbought Stochastic Strength 0.30%
Stochastic Sell Signal Bearish 0.71%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.71%

Older signals for BAX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in two segments, BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. It also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies; and to treat end-stage renal disease or irreversible kidney failure. In addition, this segment manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes products for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. serves hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and patients at home under physician supervision in the United States, Europe, the Asia-Pacific, Latin America, and Canada. The company sells its products through its direct sales force, as well as to and through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. Baxter International Inc. was founded in 1931 and is based in Deerfield, Illinois.
Medicine Infectious Diseases Disorders Dialysis Membrane Technology Hemodialysis Nutrition Products End Stage Renal Disease Hemophilia Kidney Renal Dialysis Burns Kidney Dialysis Kidney Disease Antitrypsin Deficiency Nephrology Drug Wholesalers Kidney Failure Peritoneal Dialysis Alpha 1 Antitrypsin Biosurgery Products Immune Disorders Shock
Is BAX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 89.93
52 Week Low 61.4
Average Volume 3,021,805
200-Day Moving Average 80.6943
50-Day Moving Average 83.6854
20-Day Moving Average 79.1825
10-Day Moving Average 80.757
Average True Range 1.3932
ADX 19.35
+DI 23.6672
-DI 20.6366
Chandelier Exit (Long, 3 ATRs ) 84.1604
Chandelier Exit (Short, 3 ATRs ) 79.8496
Upper Bollinger Band 82.8243
Lower Bollinger Band 75.5407
Percent B (%b) 0.92
BandWidth 9.198497
MACD Line -0.4638
MACD Signal Line -1.1325
MACD Histogram 0.6687
Fundamentals Value
Market Cap 44.82 Billion
Num Shares 545 Million
EPS 1.65
Price-to-Earnings (P/E) Ratio 49.85
Price-to-Sales 3.44
Price-to-Book 3.85
PEG Ratio 2.01
Dividend 0.64
Dividend Yield 0.78%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 83.90
Resistance 3 (R3) 83.78 83.10 83.63
Resistance 2 (R2) 83.10 82.68 83.17 83.53
Resistance 1 (R1) 82.68 82.42 82.89 82.80 83.44
Pivot Point 82.00 82.00 82.11 82.07 82.00
Support 1 (S1) 81.58 81.58 81.79 81.70 81.06
Support 2 (S2) 80.90 81.32 80.97 80.97
Support 3 (S3) 80.48 80.90 80.88
Support 4 (S4) 80.60